Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania RH Rhode Island South Carolina South Dakota Tennessee Texas Uncategorized Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

Oklahoma

Two rules recently approved by the state Board of Pharmacy go into effect on September 11, 2020.

  1. Final rule correcting a statutory citation regarding requirements for pharmacists prescribing naloxone.
  2. Final rule updating standards for pharmacy operations. The rule prohibits pharmacists from serving as a pharmacist in charge at more than one pharmacy at a time, adds refrigerator and freezer temperature requirements, clarifies requirements for shipments of pharmaceuticals, and revises hospital pharmacy provisions.

Also in Oklahoma. The Office of the Bureau of Narcotics (OBN) recently approved five rules of interest to pharmacies.

  1. Final rule of the Bureau of Narcotics and Dangerous Drugs Control adopts regulations under OAC 475:25-1 to establish reporting requirements for manufacturers and distributors of controlled dangerous substances. The rule also differentiates between the reporting requirements for pharmaceutical manufacturers and distributors and Schedule I medical marijuana manufacturers and distributors. The rule is effective Sept. 11, 2020.
  2. Final rule of the Bureau of Narcotics and Dangerous Drugs Control amends regulations under OAC 475:30-1 to update requirements for the transmission of prescriptions to pharmacies. The rule also clarifies when a pharmacy is authorized to fill a Schedule II-IV prescription and when identification is required for purchasers of controlled dangerous substances. The rule is effective Sept. 11, 2020.
  3. Final rule of the Bureau of Narcotics and Dangerous Drugs Control amends regulations under OAC 475:45-1 to clarify the information required to be submitted to the central repository for dispensation of Schedule II-V drugs. The rule is effective Sept. 11, 2020.
  4. Emergency rule of the State Department of Health amends regulations under OAC 310:535-1 to remove the requirement that those seeking a religious or personal exemption from immunization requirements must first view an instructional presentation by a local county health department on the benefits and risks of immunizations. The rule is effective Sept. 12, 2020 and expires Sept. 14, 2021.
  5. Final rule of the State Department of Health amends regulations under OAC 310:535-1 to establish an expiration date for vaccine exemptions submitted before the student enters the seventh grade and requires the submission of a new exemption form. The rule also requires those seeking a religious or personal exemption from immunization requirements to first view an instructional presentation by a local county health department on the benefits and risks of immunizations. The rule is effective Sept. 11, 2020.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2020-09-11T13:41:50-04:00September 11, 2020|Oklahoma|

Oklahoma

The Insurance Department published a notice to announce an update to Insurance Bulletin LH 2020-02, dated March 17 and April 29, directing health insurers to take certain actions in response to the coronavirus (COVID-19) emergency. The bulletin was rescinded June 30, except for specified provisions regarding telehealth/telemedicine services, electronic signatures, timeframes for utilization review, accesses to diagnosis and treatment without preauthorization requirements, waiver of cost-sharing requirements, extended grace periods, and reasonable measures to facilitate diagnosis and treatment.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2020-07-23T13:12:49-04:00July 23, 2020|Oklahoma|

Oklahoma

Notice of the Insurance Department announces LH Bulletin 2020-03 to advise health insurers and health maintenance organizations on coverage of COVID-19 antibody testing. The department provides information on CPT codes for such tests and expects insurers to cover costs associated with FDA-approved antibody tests.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2020-06-11T10:00:12-04:00June 11, 2020|Oklahoma|

Oklahoma

On May 12th, Gov. Kevin Stitt enacted an Executive Order that removed all restrictions regarding prescriptions for Hydroxychloroquine and Chloroquine. Thus a Board of Pharmacy COVID-19 waiver is no longer necessary for dispensing Hydroxychloroquine and Chloroquine prescriptions.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2020-05-21T09:57:04-04:00May 21, 2020|Oklahoma|

Oklahoma

NACDS submitted comments to the State Bureau of Narcotics and Dangerous Drugs Control (OBNDD) on proposed rule changes pertaining to the information that pharmacies are required to report to Oklahoma’s prescription drug monitoring program (PDMP). The letter recommended that the data pharmacies are required to report should be limited to information that is required to be on a controlled substance prescription and/or required to process third party claims. NACDS also commented that costly software changes would be needed for pharmacy dispensing and management computer systems to accommodate the reporting of added data elements.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2020-03-26T09:26:04-04:00March 26, 2020|Oklahoma|

Oklahoma

March 10, 2020 is Pharmacy Legislative Day at the Capitol.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2020-03-05T11:49:16-05:00March 5, 2020|Oklahoma|

Oklahoma

NACDS submitted comments to the Health Care Authority on proposed rules enhancing drug utilization review program requirements intended to promote safe and intended use of opioid medications. 

Also in Oklahoma... NACDS submitted comments to the Board of Pharmacy urging them to amend their regulations under review to expand the administrative duties of pharmacy technicians.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2020-02-20T13:06:48-05:00February 20, 2020|Oklahoma|
Go to Top